Analytical variability of the Fibrotest proteins

被引:32
作者
Rosenthal-Allieri, MA
Peritore, ML
Tran, A
Halfon, P
Benzaken, S
Bernard, A
机构
[1] CHU Nice, Hop Archet 1, Lab Cent Immunol, Nice, France
[2] Lab Alphabio, Marseille, France
关键词
biological scores of liver fibrosis; proteins; analytical variability;
D O I
10.1016/j.clinbiochem.2004.12.012
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: The analytical variability of the Fibrotest (FT) parameters raises the issue of the test's reliability for routine use. Whereas standardization has been proposed by the International Federation of Clinical Chemistry (IFCC) for specific proteins, few data are available concerning the actual transferability of the FT proteins, i.e. haptoglobin, apolipoprotein A, and 02 macroglobulin. The aim of this study was to evaluate the analytical variability of the FT proteins. Design and methods: During the FIBROPACA study, we evaluated 112 sera from patients with hepatitis C infection who underwent liver biopsy. We compared measurements of haptoglobin, apolipoprotein (A1) and alpha(2) macroglobulin by the autoanalyzers Immage (R) (Beckman-Coulter) and the FT reference BNProspec (R) (Dade-Behring). Results: Optimal concordance was found for haptoglobin (correlation: y = 1.05x -0.09; correlation coefficient = 0.98). However, apolipoprotein A, as determined with Immage (R) was globally 12% lower than with BNProspec (R) (correlation: y = 0.88x -0.05; correlation coefficient = 0.91) and alpha(2) macroglobulin values were 40% greater with Immage (R) than with BNProspec (R) (correlation: y = 1.40x -0.46; correlation coefficient = 0.96). Conclusions: Inter-technique analytical variability of the Fibrotest parameters remains a major issue. After IFCC standardization of specific proteins, some discrepancies remain for alpha(2) macroglobulin and, to a lesser extent, for apolipoprotein (A1). National and international quality control programs would be useful to monitor analytical performance of protein assays. (c) 2005 The Canadian Society of Clinical Chemists. All rights reserved.
引用
收藏
页码:473 / 478
页数:6
相关论文
共 25 条
  • [1] ALBERS JJ, 1992, CLIN CHEM, V38, P658
  • [2] BEDOSSA P, 1994, HEPATOLOGY, V20, P15
  • [3] Bienvenu J, 1997, ANN BIOL CLIN-PARIS, V55, P37
  • [4] Protein standardization III: Method optimization basic principles for quantitative determination of human serum proteins on automated instruments based on turbidimetry or nephelometry
    Blirup-Jensen, S
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2001, 39 (11) : 1098 - 1109
  • [5] Diagnostic potential of circulating TIMP-1 and MMP-2 as markers of liver fibrosis in patients with chronic hepatitis C
    Boeker, KHW
    Haberkorn, CI
    Michels, D
    Flemming, P
    Manns, MP
    Lichtinghagen, R
    [J]. CLINICA CHIMICA ACTA, 2002, 316 (1-2) : 71 - 81
  • [6] Dati F, 1996, EUR J CLIN CHEM CLIN, V34, P517
  • [7] Noninvasive monitoring of patients with chronic hepatitis C
    Fontana, RJ
    Lok, ASF
    [J]. HEPATOLOGY, 2002, 36 (05) : S57 - S64
  • [8] Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model
    Forns, X
    Ampurdanès, S
    Llovet, JM
    Aponte, J
    Quintó, L
    Martínez-Bauer, E
    Bruguera, M
    Sánchez-Tapias, JM
    Rodés, J
    [J]. HEPATOLOGY, 2002, 36 (04) : 986 - 992
  • [9] Guechot J, 1996, CLIN CHEM, V42, P558
  • [10] HALFAN P, 2003, HEPATOLOGY, V38, P68